Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain

Background: Amplification of the MYCN oncogene is the most unfavorable genetic factor in neuroblastoma patients. However, knowledge about the clinical impact of low-level multiplication of MYCN is still insufficient. Therefore, we aimed to investigate the disease course in patients with different co...

Descripción completa

Detalles Bibliográficos
Autores principales: Szewczyk, Katarzyna, Wieczorek, Aleksandra, Młynarski, Wojciech, Janczar, Szymon, Woszczyk, Mariola, Gamrot, Zuzanna, Chaber, Radosław, Wysocki, Mariusz, Pogorzała, Monika, Bik-Multanowski, Mirosław, Balwierz, Walentyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794702/
https://www.ncbi.nlm.nih.gov/pubmed/31649880
http://dx.doi.org/10.3389/fonc.2019.01018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794702/
https://www.ncbi.nlm.nih.gov/pubmed/31649880
http://dx.doi.org/10.3389/fonc.2019.01018

Ejemplares similares